June 15, 2018 06:00 AM EDT

In the glare of an intense gene therapy spotlight, bluebird continues to tout each small step forward for its pioneering LentiGlobin

John Carroll

Editor & Founder

As one of the pioneers in the new wave of gene therapy developers, bluebird bio $blue has spent considerable time providing incremental evidence that it …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

In the glare of an intense gene therapy spotlight, bluebird continues to tout each small step forward for its pioneering LentiGlobin

John Carroll

Editor & Founder

Sign up to read this article for free.

Safety concerns and trial holds for pediatric RSV vaccines prompt caution from FDA adcomm

Inside Isomorphic Labs: Demis Hassabis’ lab-free vision for biotech’s AI future

Lonza looks to depart capsule and health ingredients as it undergoes restructure

'Serious liver injury' cases lead FDA to call for monitoring of Ocaliva patients

Pfizer shares positive Phase 3 results in breast cancer subset

The key to faster, more impactful research? Put patients in the driver’s seat

In the glare of an in­tense gene ther­a­py spot­light, blue­bird con­tin­ues to tout each small step for­ward for its pi­o­neer­ing Lenti­Glo­bin

John Carroll

Editor & Founder

Sign up to read this article for free.

Safe­ty con­cerns and tri­al holds for pe­di­atric RSV vac­cines prompt cau­tion from FDA ad­comm

In­side Iso­mor­phic Labs: Demis Has­s­abis’ lab-free vi­sion for biotech’s AI fu­ture

Lon­za looks to de­part cap­sule and health in­gre­di­ents as it un­der­goes re­struc­ture

'Se­ri­ous liv­er in­jury' cas­es lead FDA to call for mon­i­tor­ing of Ocali­va pa­tients

Pfiz­er shares pos­i­tive Phase 3 re­sults in breast can­cer sub­set

The key to faster, more im­pact­ful re­search? Put pa­tients in the dri­ver’s seat

In the glare of an intense gene therapy spotlight, bluebird continues to tout each small step forward for its pioneering LentiGlobin

Safety concerns and trial holds for pediatric RSV vaccines prompt caution from FDA adcomm

Inside Isomorphic Labs: Demis Hassabis’ lab-free vision for biotech’s AI future

Lonza looks to depart capsule and health ingredients as it undergoes restructure

'Serious liver injury' cases lead FDA to call for monitoring of Ocaliva patients

Pfizer shares positive Phase 3 results in breast cancer subset

The key to faster, more impactful research? Put patients in the driver’s seat